News & Press Releases Swedish

Scandinavian ChemoTech ger en lägesrapport och önskar alla en trevlig midsommar och semester

Det har varit full fart för både Human och Animal Care under årets första 6 månader som fyllts av både kliniska framsteg och etablering av nya samarbetspartners för de båda affärsområdena.

Read more

Scandinavian ChemoTech anlitar IR-konsult

Scandinavian ChemoTech AB (publ) har anlitat Jonathan Furelid som IR-konsult för att stärka kommunikationen mot aktiemarknaden.

Read more

Scandinavian ChemoTech tecknar avtal med Kalqyl om uppdragsanalys

Scandinavian ChemoTech AB har ingått avtal med Kalqyl AB om att genomföra en initieringsanalys av Bolaget.

Read more

News & Press Releases English

Scandinavian ChemoTech provides a status report and wishes everyone a pleasant midsummer and holiday

It has been full speed ahead for both Human and Animal Care during the first 6 months of the year, which has been filled with both clinical progress and the establishment of new partners for the two business areas.

Read more

Scandinavian ChemoTech hires investor relations consultant

Scandinavian ChemoTech AB (publ) has hired Jonathan Furelid as an investor relations consultant in order to strengthen the company's communication with its stakeholders.

Read more

Scandinavian ChemoTech signs commissioned research agreement with Kalqyl

Scandinavian ChemoTech AB has entered into an agreement with Kalqyl AB to carry out an initial analysis of the Company.

Read more

ChemoTech Videos

2022

SWECARE at EXPO 2020 DUBAI: "Closing Ceremony"

A conversation with Småbolagspodden

(Audio in Swedish)

I det senaste avsnittet av Småbolagspodden berättar Scandinavian ChemoTechs vd Mohan Frick om hur bolagets unika metod för cancerbehandling, via så kallad tumörspecifik elektroporation, ska hjälpa människor och djur världen över.

Lyssna på hela avsnittet här:
52. ChemoTech – Vill vara en kraft för skonsammare cancervård

2021

Presentation of Q3 - Analysera med oss November 2021 (Swedish)

ChemoTech presents for its upcoming Annual General meeting 24 May 2021. Spoken language is Swedish but the presentation is in English.

Innovative TSE technology increases the local effect of chemotherapy (Swedish)

ChemoTech answers questions from the shareholders; Part 1 (Swedish)

CEO Mohan Frick presenting at Erik Penser Bank Bolagsdag (Swedish)

Erik Penser Bank interview with CEO Mohan Frick (Swedish) 8 January 2021

Videos from 2020

Company Presentation of the Q3 report (Swedish) 11th of November 2020

Company Presentation (Swedish) 27th of October 2020

Videos from 2019

Share Day in Gothenburg, November 4 2019 (Swedish)

Videos from 2018

Share analysis ChemoTech Q2 2018 (Swedish)

Share Day in Malmö on May 22, 2018 (Swedish)

Our foundation

Our profound knowledge in electroporation forms the starting point for the company’s existing product and R&D projects: The IQwave™ specially designed for our TSE™ – Tumour Specific Electroporation technology which treats a range of various tumours.

Our research focus

Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.